Publications by authors named "Rivera-Woll L"

Summary: Congenital hyperinsulinism is the leading cause of persistent hypoglycaemia in infants and children; however, it is uncommon to be diagnosed in adulthood. We describe the cases of two sisters who presented with hyperinsulinaemic hypoglycaemia aged 47 and 57 years old, who were subsequently diagnosed with compound heterozygous likely pathogenic variants in the ABCC8 gene, a known cause of monogenic congenital hyperinsulinism. We discuss the typical presenting features, investigation findings, and treatment strategies for patients with this condition.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to evaluate the impact of subclinical thyroid disease on quality of life and cardiovascular risk in women.
  • A total of 1423 community-dwelling women aged 18-75 were analyzed by measuring thyroid hormone levels, well-being scores, and cardiovascular risk markers.
  • Results showed no significant differences in health-related quality of life or cardiovascular risk markers between women with subclinical hypothyroidism or hyperthyroidism and age-matched controls.
View Article and Find Full Text PDF

The climacteric is not a condition of the modern age, although with increased life expectancy over the centuries, more women will experience this physiological transition. As women are living longer there is a greater expectation that good health will be maintained through to the late decade. Thus the potential long-term adverse health consequences of using hormonal therapies (HTs) to alleviate menopausal symptoms are of considerable concern for women and medical practitioners.

View Article and Find Full Text PDF

The proposed key symptoms of the female androgen insufficiency syndrome (FAIS) include reduced libido, diminished well being and lowered mood. The diagnosis of FAIS is made on the basis of these symptoms in the setting of a low serum free testosterone level. However, there is currently no readily available inexpensive assay which reliably measures free testosterone levels in the female range.

View Article and Find Full Text PDF

The use of postmenopausal hormone therapy (HT) has recently generated much debate following the results of various large randomised controlled trials. This has challenged physicians to reassess the use of HT in each individual woman within the realm of her symptomatology and risk profile for long-term illnesses. There are several areas of definite benefit or risk and many areas of uncertainty.

View Article and Find Full Text PDF